• David P. Perry
  Chief Executive Officer
• Karl R. Beutner, M.D., Ph.D.
  Senior Vice President and Chief Medical Officer
• Christine E. Gray-Smith
  Senior Vice President and Chief Financial Officer
• Kirk R. Maples, Ph.D.
  Senior Vice President, Program Management
• Jacob J. Plattner, Ph.D.
  Senior Vice President, Research
• Irwin A. Heyman, Ph.D.
  Senior Vice President, Product Development
• Kurt R. Jarnagin, Ph.D.
  Vice President, Biological Research
• James R. Marconi
  Vice President, Finance and Controller
• Lee T. Zane, M.D.
  Vice President, Clinical Development

David P. Perry
Chief Executive Officer

David P. Perry, has served as Anacor's President and Chief Executive Officer since March 2002 and has been a member of the board of directors since April 2002. In 1997, Mr. Perry founded Chemdex Corporation, which was acquired by NexPrise, Inc., a business-to-business marketplace company that focused on the life-sciences industry, and until November 2001 served as its Chief Executive Officer. In 1995, Mr. Perry co-founded Virogen, a biotech company based in Boston. Mr. Perry has a B.S. from the University of Tulsa and an M.B.A. from Harvard Business School.